Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort
Abstract Background Metabolic syndrome (MetS) has been proposed as a clinically identifiable high-risk state for the prediction and prevention of cardiovascular diseases and type 2 diabetes mellitus. As a promising “omics” technology, metabolomics provides an innovative strategy to gain a deeper und...
Main Authors: | Hao Wang, Youxin Wang, Xingang Li, Xuan Deng, Yuanyuan Kong, Wei Wang, Yong Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-022-01716-0 |
Similar Items
-
Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
by: Kelechi Njoku, et al.
Published: (2020-07-01) -
Plasma Metabolome Normalization in Rheumatoid Arthritis Following Initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy
by: Matthew R. Medcalf, et al.
Published: (2021-11-01) -
Metabolomics identify serum biomarkers for predicting acute exacerbation and severity of bronchiectasis
by: Jiaxin Yan, et al.
Published: (2025-03-01) -
Nontargeted and targeted metabolomics approaches reveal the key amino acid alterations involved in multiple myeloma
by: Lingling Yue, et al.
Published: (2022-02-01) -
Metabolomics in oncology
by: Gurparsad Singh Suri, et al.
Published: (2023-03-01)